PIROLA, ALESSANDRA
 Distribuzione geografica
Continente #
NA - Nord America 6.738
AS - Asia 3.285
EU - Europa 3.190
SA - Sud America 489
AF - Africa 77
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 7
Totale 13.801
Nazione #
US - Stati Uniti d'America 6.562
SG - Singapore 1.181
CN - Cina 744
DE - Germania 659
IT - Italia 514
VN - Vietnam 428
RU - Federazione Russa 414
SE - Svezia 400
BR - Brasile 365
HK - Hong Kong 364
IE - Irlanda 324
GB - Regno Unito 207
UA - Ucraina 196
FR - Francia 168
CA - Canada 123
IN - India 120
FI - Finlandia 80
TR - Turchia 69
BD - Bangladesh 62
AR - Argentina 46
IQ - Iraq 43
ID - Indonesia 41
KR - Corea 39
PL - Polonia 39
JP - Giappone 35
DK - Danimarca 34
ES - Italia 34
BE - Belgio 31
ZA - Sudafrica 30
MX - Messico 29
PK - Pakistan 27
NL - Olanda 24
CO - Colombia 18
SA - Arabia Saudita 18
AT - Austria 17
EC - Ecuador 17
PH - Filippine 15
VE - Venezuela 14
AU - Australia 13
UZ - Uzbekistan 13
CH - Svizzera 10
JO - Giordania 10
KE - Kenya 10
LT - Lituania 10
CL - Cile 9
IR - Iran 9
MA - Marocco 8
AE - Emirati Arabi Uniti 7
EU - Europa 7
NP - Nepal 7
OM - Oman 7
PE - Perù 7
PY - Paraguay 7
AZ - Azerbaigian 6
CZ - Repubblica Ceca 6
TN - Tunisia 6
DO - Repubblica Dominicana 5
EG - Egitto 5
ET - Etiopia 5
IL - Israele 5
MY - Malesia 5
PS - Palestinian Territory 5
TH - Thailandia 5
JM - Giamaica 4
LB - Libano 4
RO - Romania 4
UY - Uruguay 4
BG - Bulgaria 3
KG - Kirghizistan 3
LV - Lettonia 3
MU - Mauritius 3
AM - Armenia 2
BO - Bolivia 2
BW - Botswana 2
CR - Costa Rica 2
GR - Grecia 2
GT - Guatemala 2
HN - Honduras 2
LY - Libia 2
MG - Madagascar 2
NI - Nicaragua 2
NO - Norvegia 2
PA - Panama 2
RS - Serbia 2
SC - Seychelles 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BM - Bermuda 1
BS - Bahamas 1
CY - Cipro 1
DZ - Algeria 1
EE - Estonia 1
GE - Georgia 1
HU - Ungheria 1
KH - Cambogia 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
Totale 13.791
Città #
Ann Arbor 1.069
Singapore 692
Ashburn 632
Woodbridge 418
Fairfield 378
San Jose 368
Houston 354
Frankfurt am Main 350
Hong Kong 350
Chandler 347
Dublin 315
Wilmington 250
Milan 244
Dearborn 225
Jacksonville 178
Seattle 171
New York 164
Los Angeles 141
Beijing 138
Cambridge 123
Ho Chi Minh City 118
Santa Clara 102
Hanoi 88
Princeton 86
Dallas 78
The Dalles 74
Chicago 72
Nanjing 65
Göttingen 61
Shanghai 58
Lauterbourg 50
Munich 46
São Paulo 46
Buffalo 41
Altamura 37
Lawrence 36
Moscow 36
Seoul 34
Hefei 32
Jakarta 32
Brussels 31
Helsinki 31
Orem 30
Lachine 29
Boardman 28
Ottawa 28
Nanchang 26
Shenyang 25
Warsaw 24
Dong Ket 23
London 23
Montreal 23
Da Nang 22
Guangzhou 22
San Diego 22
Fürstenwalde 21
Council Bluffs 20
Johannesburg 20
Tokyo 20
Andover 19
Fremont 19
Kocaeli 19
Baghdad 18
Chennai 18
Falls Church 17
Toronto 17
Hebei 16
Nuremberg 16
Tianjin 16
Changsha 15
Denver 15
Stockholm 15
Brooklyn 14
Haiphong 14
Boston 13
Lissone 13
Manchester 13
Phoenix 13
Pune 13
Jiaxing 12
Jinan 12
Kunming 12
Mumbai 12
Ankara 11
Atlanta 11
Brasília 11
Edmonton 11
Lahore 11
Norwalk 11
Tashkent 11
Amman 10
Can Tho 10
Mexico City 10
Pavia 10
Rio de Janeiro 10
Riyadh 10
Salt Lake City 10
Charlotte 9
Chengdu 9
Curitiba 9
Totale 9.102
Nome #
De novo UBE2A mutations are recurrently acquired during chronic myeloid leukemia progression and interfere with myeloid differentiation pathways 599
A bioinformatics procedure to identify and annotate somatic mutations in whole-exome sequencing data 511
OncoScore: A novel, Internet-based tool to assess the oncogenic potential of genes 451
Age and dPCR can predict relapse in CML patients who discontinued imatinib: The ISAV study 447
RNA-seq is a valuable complement of conventional diagnostic tools in newly diagnosed AML patients 443
The Risk of Relapse in CML Patients Who Discontinued imatinib Can Be Predicted Based on Patients Age and the Results of dPCR Analysis 426
SETBP1 induces transcription of a network of development genes by acting as an epigenetic hub 410
Recurrent SETBP1 mutations in atypical chronic myeloid leukemia 407
WHOLE-EXOME SEQUENCING OF A PHILADELPHIA NEGATIVE CHRONIC MYELOID LEUKEMIA PATIENT THROUGH THE EXON-CAPTURE TECHNIQUE 390
Erratum: OncoScore: a novel, Internet-based tool to assess the oncogenic potential of genes 389
A computational procedure to identify and annotate somatic mutations in next-generation sequencing data 385
Integrated Genomic, Functional, and Prognostic Characterization of Atypical Chronic Myeloid Leukemia 375
Synergistic activity of ALK and mTOR inhibitors for the treatment of NPM-ALK positive lymphoma 363
Concomitant BCORL1 and BRAF Mutations in Vemurafenib-Resistant Melanoma Cells 359
Recurrent ETNK1 mutations in atypical chronic myeloid leukemia 357
Evidence of ETNK1 Somatic Variants in Atypical Chronic Myeloid Leukemia 342
Whole-Exome Sequencing Data - Identifying Somatic Mutations 333
Identification of novel point mutations in splicing sites integrating whole-exome and RNA-seq data in myeloproliferative diseases 313
Treatment efficacy and resistance mechanisms using the second-generation ALK inhibitor AP26113 in human NPM-ALK-positive anaplastic large cell lymphoma 310
Oncoscore, a Novel, Internet-Based Tool to Assess the Oncogenic Potential of Genes Can Differentiate Between CP-CML and BC-CML Associated Genes, and Between CP-CML Patients with Good and Bad Prognosis 308
CEQer: A Graphical Tool for Copy Number and Allelic Imbalance Detection from Whole-Exome Sequencing Data 306
Integrated Analysis of Whole-Exome Sequencing and Micrornas Expression in Blast Crisis Transformation of Chronic Myeloid Leukemia 302
Gene expression signature of non-involved lung tissue associated with survival in lung adenocarcinoma patients 298
Recurrent SETBP1 Mutations in Atypical Chronic Myeloid Leukemia 296
Read-through transcripts in normal human lung parenchyma are down-regulated in lung adenocarcinoma 292
BCR and BCR-ABL regulation during myeloid differentiation in healthy donors and in chronic phase/blast crisis CML patients 291
Recurrent somatic mutations of FAT family cadherins induce an aggressive phenotype and poor prognosis in anaplastic large cell lymphoma 277
ETNK1 is an early event and SETBP1 a late event in atypical Chronic Myeloid Leukemia 277
FusionAnalyser: a new graphical, event-driven tool for fusion rearrangements discovery 274
Identification of a Novel Splicing Mutation in Blast Crisis Transformation of Chronic Myeloid Leukemia Integrating Whole-exome and RNA-Seq data 269
CML Patients Present Additional Mutations in Cancer Related Genes When Tested At Diagnosis 268
Recurrent KIT D816V Mutation in Atypical Chronic Myeloid Leukemia 260
Synergistic activity of the Src/Abl inhibitor bosutinib in combination with imatinib 255
Identification of Novel Point Mutations in Splicing Sites by the Integration of Exome and RNA Sequencing Data in Myeloproliferative Diseases 247
Whole-exome sequencing of matched chronic phase and blast crisis CML samples to reveal mechanisms of blast crisis transformation 247
Clonal evolution analysis identifies ETNK1 as an early event and SETBP1 as a late event in atypical Chronic Myeloid Leukemia 247
Abstract 3583: Drug-resistant NPM/ALK mutants show different sensitivity to second generation tyrosine kinase inhibitors 240
Whole-Exome Sequencing of 8 Atypical Chronic Myeloid Leukaemia Patients 239
NPM/ALK mutants resistant to ASP3026 display variable sensitivity to alternative ALK inhibitors but succumb to the novel compound PF-06463922 231
BCR AND BCR-ABL REGULATION DURING MYELOID DIFFERENTIATION IN HEALTHY DONORS AND CHRONIC PHASE-BLAST CRISIS CML PATIENTS 228
Synergistic Activity of ALK and mTOR Inhibitors for the Treatment of NPM-ALK Positive Lymphoma 214
Gut virome-colonising Orthohepadnavirus genus is associated with ulcerative colitis pathogenesis and induces intestinal inflammation in vivo 198
Erratum: Treatment efficacy and resistance mechanisms using the second-generation ALK inhibitor AP26113 in human NPM-ALK-positive anaplastic large cell lymphoma (Molecular Cancer Research (2015) 13 (775-783)) 189
Identification of genetic polymorphisms modulating nausea and vomiting in two series of opioid-treated cancer patients 185
Mechanisms of resistance to the second-generation ALK inhibitor AP26113 in human NPM-ALK-positive anaplastic large cell lymphoma cells 146
Totale 14.194
Categoria #
all - tutte 41.494
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.494


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021187 0 0 0 0 0 0 0 0 0 0 82 105
2021/2022637 47 70 75 52 32 61 36 33 33 64 51 83
2022/20231.330 143 400 129 128 104 196 12 76 79 17 28 18
2023/2024886 27 35 34 53 110 270 176 12 49 25 8 87
2024/20251.919 135 166 120 97 194 74 113 72 164 360 161 263
2025/20264.541 610 209 387 595 622 251 761 173 408 478 47 0
Totale 14.194